comprehensive -WSS

comprehensive

author：explore 2025-08-19 18:02:37 - browse：23

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Making the case for fair compensation in clinical trials

WSS

Scrutiny of post

Study finds gene variants tied to breast cancer risk in Black women

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Eyeing GLP

Listen: More tumult at BIO & coercive care for sickle cell patients

Burning questions for the 2024 JPM Healthcare Conference

focus

comprehensive

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

For longer

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

UnitedHealth argues against case alleging wrongful AI care denials

Hepatitis C has a cure — but many Americans still lack access to it

How a scoliosis diagnosis changed the life of one young dancer

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Ahead of JPM, here's who's profiting most in health care

Trump demands the U.S. pay no more for drugs than other countries … again

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Wikipedia

Scrutiny of post

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Investigation reveals sickle cell patients pressured into sterilizations

Questions and answers about ramping up H5N1 bird flu vaccine

Federal weight loss drug coverage is 30 years out of date

ASCO eve: Let’s set the table for this year's meeting

explore

knowledge

Wikipedia

hotspot